Busy Philipps Shines Spotlight on ADHD in Women and Shares Her Qelbree Story

Busy is getting candid about navigating her ADHD diagnosis and treatment experience with QelbreeThe percentage of women newly diagnosed with ADHD between 23-29 and 30-49 years of age nearly doubled in just two

GlobeNewswireMay 1 20:00

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

ROCKVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous

GlobeNewswireApr 25 04:05

Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Neogen (NEOG) and Supernus Pharmaceuticals (SUPN)

TipRanksApr 15 19:10

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37

Supernus Pharmaceuticals Shares Slip 6.9% After FDA Says Drug Application Not Ready

By Ben Glickman Shares of Supernus Pharmaceuticals dropped Monday after regulators determined the company's new drug application was not ready for approval. The stock was down 6.9% to $31.23 in afte

WSJApr 9 01:49

Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease

On Monday, Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) announced a regulatory update for SPN-830, an investigational apomorphine infusion device under FDA review for the continuous treatment of motor

BenzingaApr 8 22:11